DOTZ NANO LIMITED — Board/Management Information 2021

Sep 1, 2021

2 September 2021

==> picture [97 x 47] intentionally omitted <==

ASX and MEDIA RELEASE

Dotz appoints new CEO and Non-Exec Director

Dotz Nano Limited ( ASX:DTZ ) (“ Dotz ” or the “ Company ”), an advanced technology company developing, manufacturing and commercialising marking, tracking and verification and diagnostic solutions, has appointed Mr Gideon Shmuel to the role of Executive Director and Chief Executive Officer and Cyprus/Australian-based Ms Kerry Harpaz as a Non-Executive Director. Both appointments are effective immediately.

Mr Shmuel is a highly-experienced CEO and senior executive with strong sales, business development and marketing expertise. He has extensive experience scaling innovative tech companies globally, and is the previous CEO of AI computer vision company Cipia and aerospace digital e-commerce platform ePlane. More recently, Mr Shmuel is a venture partner at London-based venture capital firm Downing Ventures.

Mr Shmuel’s appointment follows a comprehensive executive search and selection process by the Board. With the appointment of Mr Shmuel, Bernie Brookes will now move back to the role of Independent Non-executive Chairman.

Dotz has also strengthened the Board’s business capability, appointing accomplished executive Mrs Kerry Harpaz as a Non-Executive Director. Mrs Harpaz, LLB, has more than 17 years of experience in senior management and leadership with speciality in building large teams with a focus on coaching and mentoring to build successful cultures.

Commenting on the appointments, Dotz Chairman Bernie Brookes AM said, “Gideon is an experienced CEO, with a proven record of successfully scaling global technology businesses from growth through to profitability. As CEO, Gideon will ramp-up Dotz’s commercialisation efforts across the diagnostics, authentication and surface sanitisation solutions with his strong background in sales, marketing and business development key to converting our growing pipeline of opportunities.

“Kerry has a history of investing and supporting start-up businesses, and we’re delighted to welcome her to the Dotz Board. Her hands-on experience building a profitable business will be invaluable as we continue to fulfill our existing authentication and diagnostic orders, and secure new long-term commercial contracts across our three key target markets.”

CEO Gideon Shmuel said, “I’m excited to build on Dotz’s achievements over the past year, and look forward to commercialising the Company’s advanced technology and materials portfolio. Our technologies provide solutions to real-world challenges being faced by organisiations, governments, healthcare facilities and commercial venues globally. Dotz’s differentiated virus detection technology has a large global addressable market, enabling fast and effective SARS-CoV-2 virus testing at scale. I see enormous potential for Dotz’s versatile end-to-end technology, which has broad applicability across multiple industries and geographies, and look forward to delivering on Dotz’s growth strategy.”

-ENDS-

This announcement has been authorized for release by the Board of Dotz Nano Limited.

1

==> picture [97 x 47] intentionally omitted <==

For further information, please contact:

Investors: Media: Eric Kuret Tristan Everett Market Eye Market Eye E: eric.kuret@marketeye.com.au E: tristan.everett@marketeye.com.au P: +61 3 9591 8904 P: +61 403 789 096

About Dotz Nano Limited

Dotz Nano Limited (ASX: DTZ) is a technology leader in research, production and marketing of anti-counterfeiting, authentication and tracing solutions.

Its unique products ValiDotz, BioDotz, Fluorensic and InSpec are exceptional solutions for numerous applications, such as: bio-imaging, liquids tagging, lubricants and DEF authentication, polymers tagging, anti-counterfeiting, brand & reputation protection and oil & gas industry.

To learn more about Dotz, please visit the website and corporate video via the following link www.dotz.tech

2

==> picture [97 x 47] intentionally omitted <==

ATTACHMENT

Mr Gideon Shmuel – Key Terms of Appointment

Commencement date:	1 September 2021
Term:	Appointment on an on-going basis subject to termination by either party (see termination and notice below)
Fixed Remuneration:	New Israeli Shekels (NIS) 66,400 per month (A$28,250 per month) _ Based on an exchange rate of NIS: A$ of 2.326:1_
Short-Term Incentives:	Short-Term Incentives of up to 30% of base salary, subject to achieving key performance indicators (KPI) defined by the Board
Long-Term Incentives*:	1. 500,000 Options (Tranche 1 Sign on Options) with an exercise price of zero. These options are escrowed to 29 March 2022 and expire 29 March 2024. 2. 2,000,000 Options (Tranche 2) with an exercise price of AUD 41.25 cents. These options vest 29 March 2022 and expire 29 March 2023. 3. 2,500,000 Options (Tranche 3) with an exercise price of AUD 48.12 cents. These options vest 29 March 2023 and expire 29 March 2024. 4. 2,500,000 Options (Tranche 4) with an exercise price of AUD 55 cents. These options vest 29 March 2024 and expire 29 March 2025. _ the Vesting of options is subject to the CEO remaining with the Company_
Termination and Notice:	This Agreement may be terminated by either the Company or the Executive, at any time by giving the other party hereto a notice period of 6 months

* The Issues of options are subject to shareholder approval.

3